Tracing the evolution of polypharmacy and contraindicated drug‒drug interactions in people living with HIV in Belgium
Polypharmacy in people living with HIV (PWH) is a growing concern. Although the level of contraindicated drug-drug interactions (DDIs) has decreased over time, it remains a significant issue. Active monitoring and the implementation of alert systems can help clinicians mitigate the risk of such interactions.
Authors
- Karine Fombellida
- Gilles Darcis (ORCID: https://orcid.org/0000-0001-8192-1351)
- Majdouline El Moussaoui (ORCID: https://orcid.org/0000-0003-2560-5199)
- Nathalie Maes (ORCID: https://orcid.org/0000-0003-2552-2422)
- Li-Cécile Destordeur
- Victoria Lopez Delhoulle
Institutions
- University of Liège (BE)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-09-22
- DOI
- https://doi.org/10.3389/fphar.2025.1632108
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fonds De La Recherche Scientifique - FNRS
- Université de Liège